NCT01500772 - Alisporivir With PEG and RBV in Protease Inhibitor (PI) Treatment Failure Patients With Chronic Hepatitis C | Biotech Hunter

Enrollment

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

May 31, 2012

Conditions

Hepatitis C

Interventions

DRUG

Alisporivir

ALV 200 mg soft gel capsules administered orally

DRUG

Peginterferon alfa-2a

PEG 180 μg administered via subcutaneous (s.c.) injection once weekly

DRUG

Ribavirin

RBV 200 mg tablets (weight-based dose: \< 75 mg = 1000 mg/day; ≥ 75 kg = 1200 mg/day) administered orally in a divided daily dose

Trial Locations (60)

10021

Novartis Investigative Site, New York

10029

Novartis Investigative Site, New York

10032

Novartis Investigative Site, New York

10126

Novartis Investigative Site, Torino

10969

Novartis Investigational Site, Berlin

Novartis Investigative Site, Berlin

13353

Novartis Investigative Site, Berlin

20099

Novartis Investigative Site, Hamburg

20122

Novartis Investigative Site, Milan

21229

Novartis Investigative Site, Baltimore

22306

Novartis Investigative Site, Alexandria

23602

Novartis Investigative Site, Newport News

24146

Novartis Investigative Site, Kiel

28222

Novartis Investigative Site, Majadanonda

30625

Novartis Investigative Site, Hanover

33136

Novartis Investigative Site, Miami

33414

Novartis Investigative Site, Wellington

34209

Novartis Investigational site, Bradenton

Novartis Investigative Site, Bradenton

35128

Novartis Investigative Site, Padua

40138

Novartis Investigative Site, Bologna

40225

Novartis Investigative Site, Düsseldorf

40237

Novartis Investigative Site, Düsseldorf

41124

Novartis Investigative Site, Modena

45267

Novartis Investigative Site, Cincinnati

50134

Novartis Investigative Site, Florence

50924

Novartis Investigational Site, Cologne

Novartis Investigative Site, Cologne

55131

Novartis Investigational Site, Mainz

Novartis Investigative Site, Mainz

55404

Novartis Investigative Site, Minneapolis

60590

Novartis Investigative Site, Frankfurt

60611

Novartis Investigative Site, Chicago

63110

Novartis Investigative Site, St Louis

69120

Novartis Investigative Site, Heidelberg

75006

Novartis Investigative Site, Paris

75246

Novartis Investigative Site, Dallas

76012

Novartis Investigative Site, Arlington

79106

Novartis Investigative Site, Freiburg im Breisgau

Novartis Investigational Site, Frieburg

85054

Novartis Investigative Site, Phoenix

90033

Novartis Investigative Site, Los Angeles

90127

Novartis Investigative Site, Palermo

92110

Novartis Investigative Site, Clichy

92114

Novartis Investigative Site, San Diego

92128

Novartis Investigative Site, San Diego

93003

Novartis Investigative Site, Ventura

93301

Novartis Investigative Site, Bakersfield

94000

Novartis Investigative Site, Créteil

95128

Novartis Investigative Site, Palo Alto

95817

Novartis Investigative Site, Sacramento

02302

Novartis Investigative Site, Brockton

02905

Novartis Investigative Site, Providence

V5Z 1J4

Novartis Investigative Site, Vancouver

v6z 2k5

Novartis Investigative Site, Vancouver

00161

Novartis Investigative Site, Roma

00909

Novartis Investigative Site, San Juan

08035

Novartis Investigative Site, Barcelona

NW3 3QG

Novartis Investigative Site, London

SE5 9RS

Novartis Investigative Site, London